Skip to main content

This job has expired

You will need to login before you can apply for a job.

Senior Director, Program Team Lead

Employer
Intellia Therapeutics
Location
Cambridge, MA
Start date
Nov 19, 2021

View more

Job Details

Why Join Intellia? 

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. 

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done. 

We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.   

How you will Achieve More with Intellia:

Intellia is searching for an experienced cross-functional leader to serve as the Program Team Lead (PTL) for an exciting new in vivo program. You will lead a multi-disciplinary program team, comprised of functional representatives from Research, Preclinical Development, Regulatory, CMC, Clinical Development, and Commercial/New Product Planning. This is a high visibility leadership position with frequent opportunities to interact with both R&D and Executive Leadership Teams. Other responsibilities include:

  • Setting clear direction and goals, ensuring the development and execution of program strategy is in line with corporate strategy and goals

  • Oversee and drive the development and communication of the Integrated Program Plan and the Global Development Plan (GDP) in partnership with the Program Leadership Team and Program Management

  • Facilitate cross-functional communication, drive strategic and operational alignment with the program team, functional leads, and Executive Leadership Team

  • Facilitate strategic scenario planning discussions, and in partnership with PM work to identify critical issues, develop contingency plans

  • Serve as the single point of accountability for the program team, and drive key program decisions through appropriate governance forums, where appropriate

  • Build high performing teams, ensuring adequate resources in place to support Program Strategy, and in partnership with Functional Leadership resolve any team performance issues, working with line managers to develop team members

  • Drive strategic & tactical program planning in partnership with PM partner, Finance and Strategy/ Portfolio Management, to inform the long-range planning process, detailed investment planning, and portfolio prioritization exercises

  • Monitor program financials, ensuring resources in place to support program goals, and escalate resource needs, where appropriate

About You:

Do you have experience in discovery and drug development, including IND/CTA submissions, and preferably experience through Phase 1 initiation? Our ideal candidate will also have demonstrated leadership experience, with the ability to influence and effectively communicate at all levels of the organization. More specifically, the ability to drive alignment with senior/executive leadership is crucial.

Meet your future team:

The Clinical Development Team at Intellia is made up of one or more people in functions related to clinical research, including but not limited to biometrics, clinical operations, clinical pharmacology, medical science, medical writing, project leadership, project management, and regulatory affairs.  We are here because we believe genome editing has incredible potential to treat and cure life-threatening and fatal diseases, and we believe Intellia has the right people, strategy, and culture to do it well.  The team is led by our CMO, a physician and medical oncologist with over 25 years of experience in large pharma and biotech drug development.  Other senior team members have 10 or years of similar experience, including many with prior direct experience in nucleic acid therapeutics and cell therapy.  Your medical colleagues at Intellia are physicians/scientists who share responsibility across the three development-stage programs as Project Leads and Medical Leads. Their responsibility will increase in the coming years as Intellia’s pipeline moves further into clinical development.

#LI-KD1

Covid-19 Vaccination Policy: Effective Monday, January 3, 2022, all Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. Requests for exemption for medical or sincerely held religious beliefs will be considered.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert